Fenomena Pengaruh Terapi Farmakologi Terhadap Kepatuhan Berobat dalam Perspektif Pasien Diabetes Melitus Tipe 2

Fransiskus Samuel Renaldi, Rani Sauriasari, Woro Riyadina, Irianti Bahana Maulida

Abstract


Diabetes melitus tipe 2 merupakan penyakit yang kompleks dan membutuhkan manajemen terapi yang serius. Kepatuhan menjadi masalah utama dalam pengobatan diabetes melitus tipe 2 tersebut dan dapat berdampak pada komplikasi yang akan sulit ditangani. Penelitian ini ditujukan untuk mengungkap berbagai permasalahan yang mendorong seorang pasien memilih untuk tidak patuh sehingga dapat membantu tenaga kesehatan dalam mencari akar masalah ketidakpatuhan pada penderita diabetes melitus tipe 2. Sebanyak 30 penderita diabetes melitus tipe 2 terbagi atas beberapa golongan kriteria, yaitu komplikasi, usia, dan tingkat kepatuhan. Pemilihan pasien dilakukan menggunakan metode sampling bola salju. Pengambilan data dilakukan dengan metode wawancara mendalam pada pasien yang dilakukan dengan teknik probing melalui telepon dan observasi langsung sebagai bentuk validasi. Data diolah dengan metode transkrip dan dianalisis secara tematik untuk kemudian diinterpretasikan dalam bentuk pernyataan hasil wawancara. Dari hasil penelitian didapatkan bahwa sebagian besar pasien menggunakan metformin. Hal ini dikarenakan banyak pasien merasa sesuai dengan metformin. Metformin dapat memberikan efek normalisasi gula darah yang diharapkan dengan efek samping ke sistem gastrointestinal yang masih dapat ditolerir. Di sisi lain, terdapat beberapa pasien yang sudah merasa jenuh dengan penggunaan obat secara terus-menerus, mereka ingin segera lepas dari obat. Perbandingan manfaat yang dirasakan ketika meminum obat dan tidak juga turut memotivasi pasien dalam menggunakan obat. Dari berbagai data yang telah dihimpun dalam penelitian ini, dapat disimpulkan bahwa kepatuhan berobat sangat dipengaruhi oleh efek yang diterima pasca penggunaan.

Save to Mendeley


Keywords


Adherence; Type 2 Diabetes Mellitus; Medication Problems

Full Text:

PDF

References


Adams, A.J., Stolpe, S.F., 2016. Defining and Measuring Primary Medication Nonadherence: Development of a Quality Measure. J. Manag. Care Spec. Pharm. 22, 516–523. https://doi.org/10.18553/jmcp.2016.22.5.516

Akmal, M., Wadhwa, R., 2020. Alpha Glucosidase Inhibitors, in: StatPearls. StatPearls Publishing, Treasure Island (FL).

American Diabetes Association, 2020. 9. Pharmacologic Approaches to Glycemic Treatment: Standards of Medical Care in Diabetes, in: Standards of Medical Care in Diabetes - 2020. American Diabetes Association, United States of America, pp. S98–S110.

Aminde, L.N., Tindong, M., Ngwasiri, C.A., Aminde, J.A., Njim, T., Fondong, A.A., Takah, N.F., 2019. Adherence to antidiabetic medication and factors associated with non-adherence among patients with type-2 diabetes mellitus in two regional hospitals in Cameroon. BMC Endocr. Disord. 19, 35. https://doi.org/10.1186/s12902-019-0360-9

Apostolova, N., Iannantuoni, F., Gruevska, A., Muntane, J., Rocha, M., Victor, V.M., 2020. Mechanisms of action of metformin in type 2 diabetes: Effects on mitochondria and leukocyte-endothelium interactions. Redox Biol. 34, 101517. https://doi.org/10.1016/j.redox.2020.101517

Arif, N., 2020. I Illness Belief dan Illness Representation pada Pasien Diabetes Mellitus: Study Phenomenologhy. J. Med. Karya Ilm. Kesehat. 5. https://doi.org/10.35728/jmkik.v5i1.112

Armalia, N., Herawati, T., 2020. Continuous Glucose Monitoring System (CGMS) Pada Penderita Diabetes Mellitus : Tinjauan Literatur. Real Nurs. J. 3, 95–105. https://doi.org/10.32883/rnj.v3i2.879

Aronson, R., 2012. The Role of Comfort and Discomfort in Insulin Therapy. Diabetes Technol. Ther. 14, 741–747. https://doi.org/10.1089/dia.2012.0038

Artasensi, A., Pedretti, A., Vistoli, G., Fumagalli, L., 2020. Type 2 Diabetes Mellitus: A Review of Multi-Target Drugs. Molecules 25. https://doi.org/10.3390/molecules25081987

Bennich, B.B., Munch, L., Overgaard, D., Konradsen, H., Knop, F.K., Røder, M., Vilsbøll, T., Egerod, I., 2020. Experience of family function, family involvement, and self-management in adult patients with type 2 diabetes: A thematic analysis. J. Adv. Nurs. 76, 621–631. https://doi.org/10.1111/jan.14256

Butler, A.M., Georges, T., Anderson, B.J., 2020. Family Influences, in: Delamater, A.M., Marrero, D.G. (Eds.), Behavioral Diabetes: Social Ecological Perspectives for Pediatric and Adult Populations. Springer International Publishing, Cham, pp. 105–120. https://doi.org/10.1007/978-3-030-33286-0_9

Coll, A.P., Chen, M., Taskar, P., Rimmington, D., Patel, S., Tadross, J.A., Cimino, I., Yang, M., Welsh, P., Virtue, S., Goldspink, D.A., Miedzybrodzka, E.L., Konopka, A.R., Esponda, R.R., Huang, J.T.-J., Tung, Y.C.L., Rodriguez-Cuenca, S., Tomaz, R.A., Harding, H.P., Melvin, A., Yeo, G.S.H., Preiss, D., Vidal-Puig, A., Vallier, L., Nair, K.S., Wareham, N.J., Ron, D., Gribble, F.M., Reimann, F., Sattar, N., Savage, D.B., Allan, B.B., O’Rahilly, S., 2020. GDF15 mediates the effects of metformin on body weight and energy balance. Nature 578, 444–448. https://doi.org/10.1038/s41586-019-1911-y

Dey, S., Choudhury, B., Sharanya, S., 2020. Diabetes and its Complication Prediction using Multi-Task Learning. Int. J. Innov. Technol. Explor. Eng. 9, 1426–1430. https://doi.org/10.35940/ijitee.E2821.039520

Goodman, L.S., Brunton, L.L., Chabner, B., Knollmann, B.C., 2011. Goodman & Gilman’s pharmacological basis of therapeutics. McGraw-Hill, New York.

Guénette, L., Lauzier, S., Guillaumie, L., Giguère, G., Grégoire, J.-P., Moisan, J., 2015. Patients beliefs about adherence to oral antidiabetic treatment: a qualitative study. Patient Prefer. Adherence 413. https://doi.org/10.2147/PPA.S78628

Hamilton, M.J., McEniery, J.A., Osborne, J.M., Coulthard, M.G., 2019. Implementation and strength of root cause analysis recommendations following serious adverse events involving paediatric patients in the Queensland public health system between 2012 and 2014. J. Paediatr. Child Health 55, 1070–1076. https://doi.org/10.1111/jpc.14344

Hanson, P., Pandit, M., Menon, V., Roberts, S., Barber, T.M., 2014. Painful fat necrosis resulting from insulin injections. Endocrinol. Diabetes Metab. Case Rep. 2014. https://doi.org/10.1530/EDM-14-0073

Hu, Y., Chen, Y., 2020. Overview of Type 2 Diabetes Drugs on the Market. J. Biosci. Med. 08, 1. https://doi.org/10.4236/jbm.2020.88001

International Diabetes Federation, 2019. IDF Diabetes Atlas Ninth edition 2019. International Diabetes Federation.

Katzung, 2015. Basic and clinical pharmacology (intl ed). Mcgraw-hill Education, Europe.

Kc, S., S, S., Sk, S., Sm, S., Bk, J., 2019. Patient Characteristics Associated With Medication Adherence to Anti-Diabetic Drugs. Mymensingh Med. J. MMJ 28, 423–428.

Li, M., Shen, Q., Lu, W., Chen, J., Yu, L., Liu, S., Nie, X., Shao, L., Liu, Y., Gao, S., Hu, R., 2020. Development and evaluation of controlled release of metformin hydrochloride for improving the oral bioavailability based on a novel enteric osmotic pump capsule. J. Drug Deliv. Sci. Technol. 60, 102054. https://doi.org/10.1016/j.jddst.2020.102054

Linmans, J.J., Knottnerus, J.A., Spigt, M., 2015. How motivated are patients with type 2 diabetes to change their lifestyle? A survey among patients and healthcare professionals. Prim. Care Diabetes 9, 439–445. https://doi.org/10.1016/j.pcd.2015.02.001

Makkulawu, A., Setiadi, A.P., Rahardjo, T.B.W., Setiawan, E., 2018. The Development of a Questionnaire on Factors Affecting Non Adherence Behavior among Indonesian Elderly Population. Pharm. Sci. Res. PSR 5, 49-57–57. https://doi.org/10.7454/psr.v5i2.3881

Masi, G.N.M., Yulia, N., Masfuri, N., 2020. Motivasi Melakukan Self Monitoring Blood Glucose Dengan Diabetes Self Management Pada Pasien Diabetes Melitus Tipe 2. J. KEPERAWATAN 8.

Masica, A.L., Touchette, D.R., Dolor, R.J., Schumock, G.T., Kliethermes, M.A., Rodgers, P.T., Craft, J.L., Choi, Y.-K., Lux, L.J., Smith, S.R., 2008. Evaluation of a Medication Therapy Management Program in Medicare Beneficiaries at High Risk of Adverse Drug Events: Study Methods, in: Henriksen, K., Battles, J.B., Keyes, M.A., Grady, M.L. (Eds.), Advances in Patient Safety: New Directions and Alternative Approaches (Vol. 4: Technology and Medication Safety), Advances in Patient Safety. Agency for Healthcare Research and Quality (US), Rockville (MD).

Mertes, B., Gödde, S., Piorkowski, M., Kramer, G., Müller, U.A., Kuniss, N., 2020. Successful Treatment with Bedtime Basal Insulin Added to Metformin without Weight Gain or Hypoglycaemia over Three Years. J. Clin. Med. 9, 1153. https://doi.org/10.3390/jcm9041153

Newman, P.M., Franke, M.F., Arrieta, J., Carrasco, H., Elliott, P., Flores, H., Friedman, A., Graham, S., Martinez, L., Palazuelos, L., Savage, K., Tymeson, H., Palazuelos, D., 2018. Community health workers improve disease control and medication adherence among patients with diabetes and/or hypertension in Chiapas, Mexico: an observational stepped-wedge study. BMJ Glob. Health 3, e000566. https://doi.org/10.1136/bmjgh-2017-000566

Padhi, S., Nayak, A.K., Behera, A., 2020. Type II diabetes mellitus: a review on recent drug based therapeutics. Biomed. Pharmacother. 131, 110708. https://doi.org/10.1016/j.biopha.2020.110708

Provilus, A., Abdallah, M., McFarlane, S.I., 2011. Weight gain associated with antidiabetic medications. Therapy 8, 113–120. https://doi.org/10.2217/thy.11.8

Rajkanna, J., Martin, D., Whittle, L., Oyibo, S., 2013. Hypoglycaemia in hospital: a re-audit and root cause analysis using a hypoglycaemic events reporting system: Hypoglycaemia in hospital. Pract. Diabetes 30, 336–338. https://doi.org/10.1002/pdi.1807

Salama, H.M., Saudi, R.A., 2020. Effect of patients beliefs about medications on adherence to drugs in diabetic patients attending family medicine outpatient clinic in Ismailia, Egypt. J. Diabetes Metab. Disord. https://doi.org/10.1007/s40200-020-00587-0

Scheen, A.J., 2016. Will delayed release metformin provide better management of diabetes type 2? Expert Opin. Pharmacother. 17, 627–630. https://doi.org/10.1517/14656566.2016.1149166

Setyoadi, S., Ahsan, A., Abidin, A.Y., 2013. Hubungan Peran Kader Kesehatan Dengan Tingkat Kualitas Hidup Lanjut Usia. J. Ilmu Keperawatan J. Nurs. Sci. 1, 183–192.

Sheikhrabori, A., Dehghan, M., Ghaedi, F., Khademi, G.R., 2017. Complementary and Alternative Medicine Usage and Its Determinant Factors Among Diabetic Patients: An Iranian Case. J. Evid.-Based Complement. Altern. Med. 22, 449–454. https://doi.org/10.1177/2156587216675079

Soelistijo, S.A., Lindarto, D., Decroli, E., Permana, H., Sucipto, K.W., Kusnadi, Y., Budiman, Ikhsan, R., Sasiarini, L., Sanusi, H., 2019. Pedoman pengelolaan dan pencegahan diabetes melitus tipe 2 dewasa. PB PERKENI, Jakarta, Indonesia.

Varming, A.R., Hansen, U.M., Andrésdóttir, G., Husted, G.R., Willaing, I., 2015. Empowerment, motivation, and medical adherence (EMMA): the feasibility of a program for patient-centered consultations to support medication adherence and blood glucose control in adults with type 2 diabetes. Patient Prefer. Adherence 9, 1243–1253. https://doi.org/10.2147/PPA.S85528

Vluggen, S., Hoving, C., Schaper, N.C., de Vries, H., 2018. Exploring beliefs on diabetes treatment adherence among Dutch type 2 diabetes patients and healthcare providers. Patient Educ. Couns. 101, 92–98. https://doi.org/10.1016/j.pec.2017.07.009

Yadav, D.K., Karki, S., Mishra, A., Yadav, S., Ghimire, A., 2020. Drug Adherence and Self-management Practices among Diabetic Population in Letang, Nepal. Int. J. Ther. Appl. 37, 7.

Yuxin, H., Cuiping, J., Wen, T., Jieyuzhen, Q., Xiaoming, T., Qin, G., Haidong, W., Jiao, S., Zhijun, B., 2020. Comparison of gastrointestinal adverse events with different doses of metformin in the treatment of elderly people with type 2 diabetes. J. Clin. Pharm. Ther. 45, 470–476. https://doi.org/10.1111/jcpt.13087

Zhou, X., Siegel, K.R., Ng, B.P., Jawanda, S., Proia, K.K., Zhang, X., Albright, A.L., Zhang, P., 2020. Cost-effectiveness of Diabetes Prevention Interventions Targeting High-risk Individuals and Whole Populations: A Systematic Review. Diabetes Care 43, 1593–1616. https://doi.org/10.2337/dci20-0018




DOI: https://doi.org/10.33508/jfst.v8i2.3044